Table 2.

Levels of pyrimidine base damage are listed in terms of femtomoles of lesion per microgram of DNA ± SEM. The number in parenthesis is the number of participants in the group.^*

	d(PfpA)	d(TgpA)
BRCA mutation carriers (14)	5.9 ±1.0	2.9 ± 0.4
Healthy controls (18)	2.4 ± 0.3	1.8 ± 0.2

^*Two data points are omitted from Figs. 2 and 3 because participants did not disclose their age.